Archives for March 7, 2013

← 2013

update

EMA Expects OK for 2.6% Fees Hike in 2013

By Gareth Macdonald

Pharmaceutical firms targeting the European market should expect drug review fees to increase by 2.6 per cent from April according to the European Medicines Agency (EMA).